Pricing Log in Create free account

Belite Bio, Inc. Sponsored ADR (BLTE) vs Mirum Pharmaceuticals, Inc. (MIRM)

Belite Bio, Inc. Sponsored ADR and Mirum Pharmaceuticals, Inc. are both Biotechnology companies. Belite Bio, Inc. Sponsored ADR is the larger, with a market value of $6.2B against $5.4B — 1.1× the size. Belite Bio, Inc. Sponsored ADR has the higher net margin (0.00% vs −139.2%) and the higher return on invested capital (−9.55% vs −173.0%). Across the 12 metrics below, Belite Bio, Inc. Sponsored ADR leads on 9 and Mirum Pharmaceuticals, Inc. on 3.

Valuation

Metric BLTE MIRM Biotechnology median
P/E n/m n/m 8.50
P/S n/m 8.22 9.71
P/B 7.45 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 8.73 9.21
Earnings yield (1.91%) (18.13%) (33.15%)
Free cash flow yield (1.16%) (5.39%) (25.50%)

Profitability

Metric BLTE MIRM Biotechnology median
Gross margin — 81.72% 65.16%
Operating margin 0.00% (134.93%) 0.00%
Net margin 0.00% (139.18%) 0.00%
Free cash flow margin 0.00% (44.29%) 0.00%
Return on equity 0.00% (702.97%) (56.36%)
Return on assets (21.60%) (97.15%) (48.04%)
Return on invested capital (9.55%) (172.96%) 0.00%

Growth

Metric BLTE MIRM Biotechnology median
Revenue growth (TTM) — 44.02% 6.02%
EPS growth (last fiscal year) (95.76%) 74.59% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BLTE MIRM Biotechnology median
Debt to equity 0.00 (71.97) 0.00
Current ratio 33.56 2.86 4.72
Net debt to EBITDA 5.88 (19.11) 0.96

Dividend

Metric BLTE MIRM Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BLTE MIRM Biotechnology median
Market cap 6.15b 5.35b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack